New Delhi: The GST Council on Friday left taxes on COVID-19 vaccines and medical supplies unchanged after the BJP- and Opposition-ruled states sparred over whether the tax cut benefits will reach the common man.
Congress and other Opposition ruled states have been demanding a reduction in taxes but the central government felt the move may not result in tangible gains for people.
"It is one thing to rush to say - do this, it will benefit the common man. But when the technical, fitment and law committees go into the details, you realise that that could have collateral impact on many others," Finance Minister Nirmala Sitharaman said.
"I am not talking about the revenue generation aspect, but how many other items will get included in it as a result of which how you are going to implement it," she added.
Briefing reporters after the 43rd meeting of the GST Council, the finance minister said a ministerial panel will be constituted to decide on the rates on the vaccines and medical supplies.
The panel will submit its report by June 8.
"When actually these benefits, because they are going to manufacturers or intermediaries, (will) be passed over to the end user, the patients, on that there were different views.
"And therefore I suggested that a GoM (Group of Ministers) go into details and take a call. As a Council, we are responsible to see how it reaches the common man... the GoM will come back to us and we will take a final call," Sitharaman said.
Read More:Rahul Gandhi questions GST on Covid vaccines
Currently, 5 per cent GST is levied on domestically manufactured vaccines, while it is 12 per cent for COVID drugs and oxygen concentrators.
"The interest of the Centre and all states/UTs is to ensure that Indians get vaccinated in time and that states get due share of revenue in time, a balanced view is maintained, as witnessed in today's meeting," Sitharaman said.